Literature DB >> 11284738

Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor.

J Munday1, S Kerr, J Ni, A L Cornish, J Q Zhang, G Nicoll, H Floyd, M G Mattei, P Moore, D Liu, P R Crocker.   

Abstract

Here we characterize Siglec-10 as a new member of the Siglec family of sialic acid-binding Ig-like lectins. A full-length cDNA was isolated from a human spleen library and the corresponding gene identified. Siglec-10 is predicted to contain five extracellular Ig-like domains and a cytoplasmic tail containing three putative tyrosine-based signalling motifs. Siglec-10 exhibited a high degree of sequence similarity to CD33-related Siglecs and mapped to the same region, on chromosome 19q13.3. The expressed protein was able to mediate sialic acid-dependent binding to human erythrocytes and soluble sialoglycoconjugates. Using specific antibodies, Siglec-10 was detected on subsets of human leucocytes including eosinophils, monocytes and a minor population of natural killer-like cells. The molecular properties and expression pattern suggest that Siglec-10 may function as an inhibitory receptor within the innate immune system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11284738      PMCID: PMC1221762          DOI: 10.1042/0264-6021:3550489

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.

Authors:  J Gaddy; H E Broxmeyer
Journal:  Cell Immunol       Date:  1997-09-15       Impact factor: 4.868

2.  Structural basis for specificity of Grb2-SH2 revealed by a novel ligand binding mode.

Authors:  J Rahuel; B Gay; D Erdmann; A Strauss; C Garcia-Echeverría; P Furet; G Caravatti; H Fretz; J Schoepfer; M G Grütter
Journal:  Nat Struct Biol       Date:  1996-07

Review 3.  Tuning antigen receptor signaling by CD22: integrating cues from antigens and the microenvironment.

Authors:  J G Cyster; C C Goodnow
Journal:  Immunity       Date:  1997-05       Impact factor: 31.745

4.  CD22 is a negative regulator of B-cell receptor signalling.

Authors:  L Nitschke; R Carsetti; B Ocker; G Köhler; M C Lamers
Journal:  Curr Biol       Date:  1997-02-01       Impact factor: 10.834

5.  Sialylation of the B lymphocyte molecule CD22 by alpha 2,6-sialyltransferase is implicated in the regulation of CD22-mediated adhesion.

Authors:  S Braesch-Andersen; I Stamenkovic
Journal:  J Biol Chem       Date:  1994-04-22       Impact factor: 5.157

6.  Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules.

Authors:  S D Freeman; S Kelm; E K Barber; P R Crocker
Journal:  Blood       Date:  1995-04-15       Impact factor: 22.113

7.  Conservation of functionally important epitopes on myelin associated glycoprotein (MAG).

Authors:  M B Tropak; G F Jansz; W Abramow-Newerly; J C Roder
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  1995-10       Impact factor: 2.231

8.  Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily.

Authors:  S Kelm; A Pelz; R Schauer; M T Filbin; S Tang; M E de Bellard; R L Schnaar; J A Mahoney; A Hartnell; P Bradfield
Journal:  Curr Biol       Date:  1994-11-01       Impact factor: 10.834

9.  Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells.

Authors:  M Falco; R Biassoni; C Bottino; M Vitale; S Sivori; R Augugliaro; L Moretta; A Moretta
Journal:  J Exp Med       Date:  1999-09-20       Impact factor: 14.307

Review 10.  Sialic acids in molecular and cellular interactions.

Authors:  S Kelm; R Schauer
Journal:  Int Rev Cytol       Date:  1997
View more
  38 in total

Review 1.  Siglecs in the immune system.

Authors:  P R Crocker; A Varki
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

Review 2.  Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?

Authors:  Huan Cao; Paul R Crocker
Journal:  Immunology       Date:  2010-11-11       Impact factor: 7.397

3.  SIGLEC-G deficiency increases susceptibility to develop B-cell lymphoproliferative disorders.

Authors:  Giorgia Simonetti; Maria Teresa Sabrina Bertilaccio; Tania Veliz Rodriguez; Benedetta Apollonio; Antonis Dagklis; Martina Rocchi; Anna Innocenzi; Stefano Casola; Thomas H Winkler; Lars Nitschke; Maurilio Ponzoni; Federico Caligaris-Cappio; Paolo Ghia
Journal:  Haematologica       Date:  2014-05-23       Impact factor: 9.941

Review 4.  The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease.

Authors:  Jennifer Müller; Lars Nitschke
Journal:  Nat Rev Rheumatol       Date:  2014-04-29       Impact factor: 20.543

5.  Expression of CD24 and Siglec-10 in first trimester placenta: implications for immune tolerance at the fetal-maternal interface.

Authors:  Marei Sammar; Monika Siwetz; Hamutal Meiri; Viktor Fleming; Peter Altevogt; Berthold Huppertz
Journal:  Histochem Cell Biol       Date:  2016-12-23       Impact factor: 4.304

Review 6.  Siglec-G/10 in self-nonself discrimination of innate and adaptive immunity.

Authors:  Guo-Yun Chen; Nicholas K Brown; Pan Zheng; Yang Liu
Journal:  Glycobiology       Date:  2014-07-04       Impact factor: 4.313

Review 7.  Siglec-mediated regulation of immune cell function in disease.

Authors:  Matthew S Macauley; Paul R Crocker; James C Paulson
Journal:  Nat Rev Immunol       Date:  2014-09-19       Impact factor: 53.106

8.  Click and pick: identification of sialoside analogues for siglec-based cell targeting.

Authors:  Cory D Rillahan; Erik Schwartz; Ryan McBride; Valery V Fokin; James C Paulson
Journal:  Angew Chem Int Ed Engl       Date:  2012-10-04       Impact factor: 15.336

Review 9.  Basic and clinical immunology of Siglecs.

Authors:  Stephan von Gunten; Bruce S Bochner
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

Review 10.  Siglecs as targets for therapy in immune-cell-mediated disease.

Authors:  Mary K O'Reilly; James C Paulson
Journal:  Trends Pharmacol Sci       Date:  2009-04-07       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.